Jim Simons Invo Bioscience, Inc. Call Options Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding INVO
# of Institutions
1Shares Held
14.1KCall Options Held
0Put Options Held
0About INVO Bioscience, Inc.
- Ticker INVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 12,169,700
- Market Cap $9.86M
- Description
- INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.